MedTrace Logo

ABO Blood Group Type Association With COVID-19 Severity

NCT05859958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 599

Last updated 2023-05-26

No results posted yet for this study

Summary

The COVID-19 pandemic has caused a significant healthcare burden and remains a heavily researched disease entity. Originating in Wuhan, China in late 2019, SARS-CoV-2 has infected over 600 million individuals worldwide. ABO blood groups have been known to increase the human body's susceptibility to different pathogens, such as hepatitis B virus, MERS-COV, SARS-COV, norovirus, and malaria, to name a few. As such, the association of ABO blood groups and COVID-19 infection and disease severity has come into question.

Conditions

Interventions

OTHER

No Intervention

Difference in outcomes in patients with COVID-19 diagnosis and ABO blood groups

Sponsors & Collaborators

  • Arrowhead Regional Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-10
Primary Completion
2023-05-10
Completion
2023-05-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05859958 on ClinicalTrials.gov